• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致病 LRRK2 R1441C 突变诱导帕金森病前体期的特定缺陷在小鼠中建模。

The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.

机构信息

Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Developmental Genetics, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; Technische Universität München-Weihenstephan, Lehrstuhl für Entwicklungsgenetik, c/o Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.

Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Developmental Genetics, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.

出版信息

Neurobiol Dis. 2017 Sep;105:179-193. doi: 10.1016/j.nbd.2017.05.013. Epub 2017 May 31.

DOI:10.1016/j.nbd.2017.05.013
PMID:28576705
Abstract

The aim of the present study was to further explore the in vivo function of the Leucine-rich repeat kinase 2 (LRRK2)-gene, which is mutated in certain familial forms of Parkinson's disease (PD). We generated a mouse model harboring the disease-associated point mutation R1441C in the GTPase domain of the endogenous murine LRRK2 gene (LRRK2 R1441C line) and performed a comprehensive analysis of these animals throughout lifespan in comparison with an existing knockdown line of LRRK2 (LRRK2 knockdown line). Animals of both lines do not exhibit severe motor dysfunction or pathological signs of neurodegeneration neither at young nor old age. However, at old age the homozygous LRRK2 R1441C animals exhibit clear phenotypes related to the prodromal phase of PD such as impairments in fine motor tasks, gait, and olfaction. These phenotypes are only marginally observable in the LRRK2 knockdown animals, possibly due to activation of compensatory mechanisms as suggested by in vitro studies of synaptic transmission. Thus, at the organismal level the LRRK2 R1441C mutation does not emerge as a loss of function of the protein, but induces mutation specific deficits. Furthermore, judged by the phenotypes presented, the LRRK2-R1441C knock-in line is a valid preclinical model for the prodromal phase of PD.

摘要

本研究旨在进一步探索富含亮氨酸重复激酶 2(LRRK2)基因的体内功能,该基因在某些家族性帕金森病(PD)中发生突变。我们构建了一种携带内源性小鼠 LRRK2 基因 GTPase 结构域中与疾病相关的点突变 R1441C 的小鼠模型(LRRK2 R1441C 系),并与现有的 LRRK2 敲低系(LRRK2 敲低系)进行了全面的比较分析。在整个生命周期中,这两个系的动物既没有表现出严重的运动功能障碍,也没有表现出神经退行性病变的病理迹象,无论是在幼年还是老年。然而,在老年时,纯合的 LRRK2 R1441C 动物表现出与 PD 前驱期相关的明显表型,如精细运动任务、步态和嗅觉受损。这些表型在 LRRK2 敲低动物中仅略微可见,这可能是由于突触传递的体外研究表明存在代偿机制。因此,在机体水平上,LRRK2 R1441C 突变不是蛋白质的功能丧失,而是诱导突变特异性缺陷。此外,从呈现的表型来看,LRRK2-R1441C 敲入系是 PD 前驱期的有效临床前模型。

相似文献

1
The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.致病 LRRK2 R1441C 突变诱导帕金森病前体期的特定缺陷在小鼠中建模。
Neurobiol Dis. 2017 Sep;105:179-193. doi: 10.1016/j.nbd.2017.05.013. Epub 2017 May 31.
2
Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.人类R1441C型亮氨酸重复激酶2(LRRK2)在帕金森病果蝇模型中调节突触小泡蛋白质组和磷酸化蛋白质组。
Hum Mol Genet. 2016 Dec 15;25(24):5365-5382. doi: 10.1093/hmg/ddw352.
3
Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.帕金森病相关的R1441C型亮氨酸重复激酶2(LRRK2)在小鼠中脑多巴胺能神经元中的条件性表达会导致核异常但无神经退行性变。
Neurobiol Dis. 2014 Nov;71:345-58. doi: 10.1016/j.nbd.2014.08.027. Epub 2014 Aug 29.
4
LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function.携带LRRK2细菌人工染色体的转基因大鼠出现进行性、对左旋多巴有反应的运动障碍以及多巴胺回路功能缺陷。
Hum Mol Genet. 2016 Mar 1;25(5):951-63. doi: 10.1093/hmg/ddv628. Epub 2016 Jan 6.
5
(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model.(R1441C)LRRK2 诱导 SN 多巴胺能神经元变性,并改变调节神经元存活的基因在转基因小鼠模型中的表达。
Exp Neurol. 2016 Jan;275 Pt 1:104-15. doi: 10.1016/j.expneurol.2015.09.001. Epub 2015 Sep 10.
6
R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations.R1441C 和 G2019S LRRK2 基因敲入小鼠具有不同的纹状体分子、生理和行为改变。
Commun Biol. 2022 Nov 10;5(1):1211. doi: 10.1038/s42003-022-04136-8.
7
Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.富含亮氨酸重复激酶2(LRRK2)/PARK8具有GTP酶活性,该活性在家族性帕金森病R1441C/G突变体中发生改变。
J Neurochem. 2007 Oct;103(1):238-47. doi: 10.1111/j.1471-4159.2007.04743.x. Epub 2007 Jul 10.
8
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.撒丁岛帕金森病患者群体中五个LRRK2突变的基因分析:G2019S和R1441C突变在散发性帕金森病患者中的重要性
Parkinsonism Relat Disord. 2009 May;15(4):277-80. doi: 10.1016/j.parkreldis.2008.06.009. Epub 2008 Sep 20.
9
Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology.帕金森病相关突变 LRRK2 G2019S 在小鼠前脑中的过表达诱导行为缺陷和 α-突触核蛋白病理学。
eNeuro. 2017 Mar 17;4(2). doi: 10.1523/ENEURO.0004-17.2017. eCollection 2017 Mar-Apr.
10
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.帕金森病 VPS35[D620N]突变增强了小鼠和人类中 LRRK2 介导的 Rab 蛋白磷酸化。
Biochem J. 2018 Jun 6;475(11):1861-1883. doi: 10.1042/BCJ20180248.

引用本文的文献

1
Affective phenotypes in heterozygous R1441G knock-in mice.杂合R1441G基因敲入小鼠的情感表型
Front Genet. 2025 Aug 29;16:1629897. doi: 10.3389/fgene.2025.1629897. eCollection 2025.
2
Microglial dynamics and neuroinflammation in prodromal and early Parkinson's disease.前驱期及早期帕金森病中的小胶质细胞动态变化与神经炎症
J Neuroinflammation. 2025 May 21;22(1):136. doi: 10.1186/s12974-025-03462-y.
3
Impairment of the trans-Golgi-Lysosomal Pathway Accelerates Dopaminergic Neuronal Senescence in LRRK2 Rats.跨高尔基体-溶酶体途径受损加速LRRK2大鼠多巴胺能神经元衰老
Aging Dis. 2024 Nov 1. doi: 10.14336/AD.2024.0883.
4
Transcriptomics and weighted protein network analyses of the LRRK2 protein interactome reveal distinct molecular signatures for sporadic and LRRK2 Parkinson's Disease.LRRK2蛋白相互作用组的转录组学和加权蛋白质网络分析揭示了散发性和LRRK2帕金森病的不同分子特征。
NPJ Parkinsons Dis. 2024 Aug 3;10(1):144. doi: 10.1038/s41531-024-00761-8.
5
Experimental Animal Models of Prodromal Parkinson's Disease.前驱期帕金森病的实验动物模型。
J Parkinsons Dis. 2024;14(s2):S369-S379. doi: 10.3233/JPD-230393.
6
Modeling Parkinson's disease in LRRK2 rodents.在携带亮氨酸重复激酶2(LRRK2)突变的啮齿动物中模拟帕金森病
Neuronal Signal. 2023 Aug 16;7(3):NS20220040. doi: 10.1042/NS20220040. eCollection 2023 Sep.
7
How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review.帕金森病啮齿动物模型对早期非运动表型的模拟效果如何?一项系统评价。
Biomedicines. 2022 Nov 24;10(12):3026. doi: 10.3390/biomedicines10123026.
8
R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations.R1441C 和 G2019S LRRK2 基因敲入小鼠具有不同的纹状体分子、生理和行为改变。
Commun Biol. 2022 Nov 10;5(1):1211. doi: 10.1038/s42003-022-04136-8.
9
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons.导致帕金森病的LRRK2突变会损害人类神经元中内源性α-突触核蛋白的生理性四聚化。
NPJ Parkinsons Dis. 2022 Sep 16;8(1):118. doi: 10.1038/s41531-022-00380-1.
10
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease.LRRK2 突变敲入鼠模型:帕金森病的治疗相关性。
Transl Neurodegener. 2022 Feb 14;11(1):10. doi: 10.1186/s40035-022-00285-2.